VaxInnate Corporation in Cranbury, NJ
You can add a company to your Saved companies to get updates.
Last Updated
01/24/2021
Location
Cranbury, NJ
Category
Biotechnology
Industry
Pharmaceutical Company
Summary
Description
VaxInnate is a vaccine company developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus.
Strengths
- VaxInnate Corporation has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since VaxInnate Corporation was founded, the company has grown faster than the industry average
Weaknesses
Annual Revenue
$19686000
Revenue per employee
$
202948
Variance of revenue growth
0.03
Annual revenue growth since founding
$
1093666
Revenue growth rate from first known quarter to current
64.0 %
Employee Count
97 employees
Employee growth rate from first known quarter to current
61.7 %
G Score
G1
Revenue is greater than the industry median.
G2
Income per employee more than industry average.
G3
Revenue growth rate from the first known quarter to current is higher than the industry average.
G4
Employee growth rate from the first known quarter to current is higher than the industry average.
G5
Variance of revenue growth is less than the industry average
G6
Annual revenue growth since founding is higher than the industry average.
Ideal Fit Acquirer
Best Private Equity firm
Edison Partners
Kona Equity can help connect VaxInnate Corporation to Edison Partners to discuss future partnerships, facilitate mergers and acquisitions conversations, financing events, and thoughts on the future.
Kona Equity has 2903 similar Biotechnology companies if you're interested in seeing other companies.
Start Now
Key Information
Name:
VaxInnate Corporation
Tags:
Pharmaceuticals; Healthcare; Biotechnology; Drug Manufacturing & Research
Category:
Biotechnology
Website:
https://www.vaxinnate.com
Industry:
Pharmaceutical Company
LinkedIn:
https://www.linkedin.com/company/vaxinnate-corporation
Funding Amount:
178.2M
SIC:
2834; 283
NAICS: